NCM · —
CJMB (CJMB) Stock
$1.57
-5.42%
NCM: CJMB
—
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Top Midday Gainers
MT Newswires · Jul 17, 2026
BC-Most Active Stocks
Associated Press · Jul 17, 2026
Top Premarket Gainers
MT Newswires · Jul 17, 2026
Callan JMB and Alabama State University Announce Strategic Partnership to Advance U.S. Pharmaceutical Manufacturing and Supply Chain Resilience
GlobeNewswire · Jul 16, 2026
Callan JMB Inc. and Alabama State University Partner to Advance Workforce Development, Research, and Pharmaceutical Innovation at the Atlas Complex
GlobeNewswire · Jul 8, 2026
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Insiders Held62.38%
Institutions Held10.53%
Institutions Float Held28.00%
Peer Comparison
About CJMB
CJMB is led by CEO Wayne Williams, employs 26 people, headquartered in US, publicly traded since 2025.
CJMB stock trades at $1.57 with a market capitalization of $7.50M. The stock is valued at a price-to-earnings (P/E) ratio of -0.40, price-to-book of 1.57, price-to-sales of 0.64. Over the past 52 weeks the stock has ranged between $0.65 and $5.88, and currently trades 73.3% below its 52-week high.
On profitability, CJMB generates a return on equity (ROE) of -400.00%, return on capital employed of -200.00%, an operating margin of -100.00%, a net profit margin of -1.85%.